CASTLE BIOSCIENCES INC's ticker is CSTL and the CUSIP is 14843C105. A total of 181 filers reported holding CASTLE BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $754,814 | +23.1% | 44,690 | 0.0% | 0.00% | – |
| Q2 2023 | $613,147 | +19.9% | 44,690 | +98.6% | 0.00% | – |
| Q1 2023 | $511,200 | -3.5% | 22,500 | 0.0% | 0.00% | – |
| Q4 2022 | $529,650 | -9.8% | 22,500 | 0.0% | 0.00% | – |
| Q3 2022 | $587,000 | -38.8% | 22,500 | -48.5% | 0.00% | – |
| Q2 2022 | $959,000 | -13.8% | 43,686 | +76.2% | 0.00% | – |
| Q1 2022 | $1,113,000 | +5.1% | 24,800 | +0.4% | 0.00% | – |
| Q4 2021 | $1,059,000 | -35.5% | 24,700 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $1,643,000 | -11.4% | 24,700 | -2.4% | 0.00% | 0.0% |
| Q2 2021 | $1,855,000 | +106.8% | 25,300 | +93.1% | 0.00% | – |
| Q1 2021 | $897,000 | +23.7% | 13,100 | +21.3% | 0.00% | – |
| Q4 2020 | $725,000 | +11.0% | 10,800 | -15.0% | 0.00% | – |
| Q3 2020 | $653,000 | +28.3% | 12,700 | -5.9% | 0.00% | – |
| Q2 2020 | $509,000 | – | 13,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 33,626 | $567,943 | 77.21% |
| Millrace Asset Group, Inc. | 77,315 | $1,306 | 1.61% |
| Granahan Investment Management | 2,487,673 | $42,016,797 | 1.50% |
| Parkman Healthcare Partners LLC | 224,592 | $3,793,359 | 0.70% |
| PERKINS CAPITAL MANAGEMENT INC | 29,160 | $493 | 0.49% |
| Capital Impact Advisors, LLC | 16,554 | $279,597 | 0.47% |
| Soleus Capital Management, L.P. | 283,500 | $4,788,315 | 0.44% |
| Portolan Capital Management | 253,028 | $4,273,643 | 0.40% |
| Numerai GP LLC | 68,163 | $1,151,273 | 0.38% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 946,620 | $15,988,412 | 0.35% |